Showing 131-140 of 327 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount | 
|---|---|---|---|---|---|
| Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes | University of Miami | Thomas Malek | Cures | 01-June-2024 to 31-May-2027 | $927.000,00 | 
| Gaining insight into type 1 diabetes pathogenesis through STAT gain of function | The Regents of the University of California, San Francisco | Martin Thelin | Cures | 01-March-2024 to 28-February-2025 | $110.000,00 | 
| Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model | Hugo W. Moser Research Institute at Kennedy Krieger | Karen Dimentstein | Transportfolio | 01-September-2024 to 31-August-2026 | $130.000,00 | 
| Preclinical Optimization of Polyclonal IgM for Type 1 Diabetes Prevention and Reversal | Rector & Visitors of the University of Virginia | Kenneth Brayman | Cures | 01-July-2024 to 30-June-2025 | $249.458,02 | 
| Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis | The University of Iowa | Samuel Stephens | Cures | 01-June-2024 to 31-May-2027 | $750.000,00 | 
| Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-June-2024 to 31-May-2026 | $500.000,00 | 
| Local bioelectronic oxygenation for islet engraftment | Carnegie Mellon University | Tzahi Cohen-Karni | Cures | 01-August-2024 to 31-July-2027 | $974.998,74 | 
| Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts | Trustees of Columbia University in the City of New York | Megan Sykes | Cures | 01-June-2024 to 31-May-2026 | $599.999,94 | 
| Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration | University of Miami | Juan Dominguez-Bendala | Cures | 01-April-2024 to 31-March-2027 | $741.000,00 | 
| Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation | University of Florida | Allison Bayer | Cures | 01-September-2023 to 31-March-2026 | $510.297,39 |